[go: up one dir, main page]
More Web Proxy on the site http://driver.im/
You seem to have javascript disabled. Please note that many of the page functionalities won't work as expected without javascript enabled.
 
 
Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Article Types

Countries / Regions

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Search Results (1,812)

Search Parameters:
Keywords = medical implants

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
19 pages, 12807 KiB  
Article
Modification of Mechanical Properties of Ti–6Al–4V Using L-PBF for Anatomical Plates
by Soumyabrata Basak, Sang-Hun Lee, Jeong-Rim Lee, Dong-Hyun Kim, Jeong Hun Lee, Myunghwan Byun and Dong-Hyun Kim
Metals 2025, 15(1), 32; https://doi.org/10.3390/met15010032 - 2 Jan 2025
Abstract
In this research, as-built Ti–6Al–4V anatomical plates were successfully fabricated using laser powder bed fusion (LPBF). This study thoroughly examines the microstructural evolution and its role in enhancing the mechanical properties of clavicle bone plates under sub-β-transus heat treatment for medical application. Scanning [...] Read more.
In this research, as-built Ti–6Al–4V anatomical plates were successfully fabricated using laser powder bed fusion (LPBF). This study thoroughly examines the microstructural evolution and its role in enhancing the mechanical properties of clavicle bone plates under sub-β-transus heat treatment for medical application. Scanning electron microscope (SEM) images of the as-built specimens reveal a dense formation of a hard α’ hcp martensite structure, which decomposes during annealing at 650 °C and ultimately transforms into an α + β lamellar structure at 950 °C. Additionally, coarse grains resulting from recrystallization and reduced dislocation density were observed through electron backscatter diffraction (EBSD) following heat treatment. Due to these microstructural evolutions, the desired mechanical properties of as-built Ti64 parts for surgical applications were achieved. Heat treatment of the anatomical plates at 950 °C demonstrated an excellent strength–ductility synergy under tensile deformation and the highest energy absorption capability under bending deformation, indicating sufficient durability for medical implantation applications. Full article
(This article belongs to the Section Additive Manufacturing)
Show Figures

Figure 1

Figure 1
<p>Schematic representation of (<b>a</b>) LPBF process for Ti–6Al–4V (SEM image of raw powder particles at inset); (<b>b</b>) Z-built clavicle bone plate, cuboid, and tensile specimen; (<b>c</b>) a 4-point bending test for clavicle bone plate.</p>
Full article ">Figure 2
<p>(<b>a</b>) 3D X-ray computed tomography analysis of pore characteristics within the as-built Ti-–6Al–4V cube specimen; (<b>b</b>) a bar chart showing the volume distribution and count of the interior pores.</p>
Full article ">Figure 3
<p>(<b>a</b>) XRD analyses of as-built and heat-treated Ti64 alloy fabricated by LPBF. (<b>b</b>,<b>c</b>) Magnified images from the marked by purple and green dashed line reveal details of peak profiling and the presence of phase constituents. β-phase peak intensity increased at 950 HT and 800 HT thermal annealing conditions.</p>
Full article ">Figure 4
<p>Dislocation density estimated by XRD peak analysis for as-built, 650 HT, 800 HT, and 950 HT.</p>
Full article ">Figure 5
<p>SEM images through build direction (<span class="html-italic">Z</span> axis) of (<b>a</b>) as-built showing α’ martensitic structures; (<b>b</b>) 650 HT showing decomposition of martensitic α’ and stable α; (<b>c</b>) 800 HT showing α + β phase; and (<b>d</b>) 950 HT showing primary α, α + β lamella, and rod-shaped β. All the conditions present the nanosized β particles.</p>
Full article ">Figure 6
<p>Inverse pole Figure (IPF) maps of the (<b>a</b>) as-built, (<b>b</b>) 650 HT, (<b>c</b>) 800 HT, and (<b>d</b>) 950 HT. The prior β grain boundaries are marked with black dashed lines.</p>
Full article ">Figure 7
<p>Kernel average misorientation (KAM) maps of the (<b>a</b>) as-built, (<b>b</b>) 650 HT, (<b>c</b>) 800 HT, and (<b>d</b>) 950 HT. The prior β grain boundaries are indicated by white dashed lines.</p>
Full article ">Figure 8
<p>Surface hardness maps sequentially for as-built, 650 HT, 800 HT, and 950 HT, respectively. Hardness decreased as the thermal annealing temperature increased to 950 HT condition.</p>
Full article ">Figure 9
<p>Engineering stress–strain curves for as-built, 650 HT, 800 HT, and 950 HT specimens.</p>
Full article ">Figure 10
<p>SEM fractography and magnified tensile fracture surface images for (<b>a,e</b>) as-built; (<b>b</b>,<b>f</b>) 650 HT; (<b>c</b>,<b>g</b>) 800 HT; (<b>d</b>,<b>h</b>) 950 HT. The fracture mode change from quasi-cleavage failure of as-built to ductile failure of 950 HT specimen.</p>
Full article ">Figure 11
<p>Plots of 4-point bending behavior (force–displacement curve) for various annealing treatment conditions: as-built, 650 HT, 800 HT, and 950 HT.</p>
Full article ">Figure 12
<p>4-point bending properties of clavicle bone plate under different conditions: (<b>a</b>) maximum load and rigidity; (<b>b</b>) energy absorption capacity in the elastic and plastic regions for as-built and heat-treated specimens.</p>
Full article ">Figure 13
<p>(<b>a</b>) Pictographs of the broken specimens after bending tests and corresponding SEM images reveal morphologies of fracture zone for (<b>b</b>–<b>b2</b>) as-built, (<b>c</b>–<b>c2</b>) 800 HT, (<b>d</b>–<b>d2</b>) 950 HT. The yellow and red arrows indicate the tearing edges and shear dimples, relatively.</p>
Full article ">
12 pages, 4465 KiB  
Article
Phase Transition and Controlled Zirconia Implant Patterning Using Laser-Induced Shockwaves
by Inomjon Majidov, Yaran Allamyradov, Salizhan Kylychbekov, Zikrulloh Khuzhakulov and Ali Oguz Er
Appl. Sci. 2025, 15(1), 362; https://doi.org/10.3390/app15010362 - 2 Jan 2025
Abstract
Zirconia is increasingly favored for dental implants owing to its corrosion resistance, hypoallergenic properties, and superior esthetics, but its biocompatibility remains a challenge. This study explores laser-assisted surface modification to enhance zirconia bioactivity. Zirconia transitions from the monoclinic to the tetragonal phase during [...] Read more.
Zirconia is increasingly favored for dental implants owing to its corrosion resistance, hypoallergenic properties, and superior esthetics, but its biocompatibility remains a challenge. This study explores laser-assisted surface modification to enhance zirconia bioactivity. Zirconia transitions from the monoclinic to the tetragonal phase during sintering, with mixed phases observed in the pre-sintered stage. These transitions are critical for understanding its structural stability and malleability. Grid patterns were imprinted on the green body implant surface using a 1064 nm Nd-YAG laser (Continuum Surelite II, San Jose, CA, USA), with mesh sizes ranging from 7 to 50 µm and depths up to 2 µm, controlled by varying laser fluence, irradiation time, and templates. SEM, AFM, and XRD analyses were used to characterize the surface morphology and crystallography. Protein adsorption studies compared two patterned samples with different surface coverage—the first sample had a patterned area of 0.212 cm2 (27%), while the second sample had a patterned area of 0.283 cm2 (36%)—to a control sample. Protein adsorption increased by 92% in the first and 169% in the second sample, demonstrating a direct correlation between increased pattern area and bioactivity. Enhanced protein adsorption facilitates cell attachment and growth, which are crucial for improving osseointegration. These results underscore the potential of laser-assisted surface modification to optimize zirconia’s performance as a medical implant material. Full article
(This article belongs to the Special Issue Advances of Laser Technologies and Their Applications)
Show Figures

Figure 1

Figure 1
<p>XRD pattern of zirconia. Sintered (red), pre-sintered (green), and green body (blue) ZrO<sub>2</sub> XRD profiles.</p>
Full article ">Figure 2
<p>ZrO<sub>2</sub> patterned via the “graphite method”. Cu (400) mesh TEM grid template at F = 1 J/cm<sup>2</sup>, t = 2 s.</p>
Full article ">Figure 3
<p>Zirconia surface patterned via the “aluminum method”. First row: Cu (400) square mesh TEM template at F = 2 J/cm<sup>2</sup>, t = 1 s. Second row: Cu (400) hexagonal mesh grid TEM template at F = 2 J/cm<sup>2</sup>, t = 1 s.</p>
Full article ">Figure 4
<p>AFM image, 3D image, and depth profile plot of a patterned zirconia via the aluminum method. Cu(400) hexagonal mesh grid TEM template at F = 2 J/cm<sup>2</sup>, t = ₋1 s. −.</p>
Full article ">Figure 5
<p>BSA absorbance as a function of time at 562 nm.</p>
Full article ">
10 pages, 2336 KiB  
Review
The Management of Postpartum Cardiorespiratory Failure in a Patient with COVID-19 and Sickle Cell Trait Requiring Extraorporeal Membrane Oxygenation Support and Airflight Transportation
by Alexandre Pelouze, Sylvain Massias, Diae El Manser, Adrien Koeltz, Patricia Shri Balram Christophe, Mohamed Soualhi and Marc Licker
J. Clin. Med. 2025, 14(1), 213; https://doi.org/10.3390/jcm14010213 - 2 Jan 2025
Abstract
Acute cardiovascular disorders are incriminated in up to 33% of maternal deaths, and the presence of sickle cell anemia (SCA) aggravates the risk of peripartum complications. Herein, we present a 24-year-old Caribbean woman with known SCA who developed a vaso-occlusive crisis at 36 [...] Read more.
Acute cardiovascular disorders are incriminated in up to 33% of maternal deaths, and the presence of sickle cell anemia (SCA) aggravates the risk of peripartum complications. Herein, we present a 24-year-old Caribbean woman with known SCA who developed a vaso-occlusive crisis at 36 weeks of gestation that required emergency Cesarean section. In the early postpartum period, she experienced fever with rapid onset of acute respiratory distress in the context of COVID-19 infection that required tracheal intubation and mechanical ventilatory support with broad-spectrum antibiotics and blood exchange transfusion. Shortly thereafter, transthoracic echocardiography documented severe biventricular dysfunction associated with raising levels of cardiac troponin and ECG signs of myocardial ischemia. Medical treatment with incremental dobutamine and noradrenaline infusion failed to improve cardiac output and blood gas exchange. After consultation with the regional cardiac center, a prompt decision was made to provide cardiac and respiratory support via implantation of femoral cannula and initiation of veno-arterial extracorporeal membrane oxygenation (ECMO, Cardiohelp®). Under stable ECMO, the patient was transferred by helicopter to a specialized cardiac center. There were no signs of ongoing hemolysis, and progressive recovery of the right and left ventricular function facilitated forward blood flow through the aortic valve. Three days after implantation, ECMO was weaned, and the cannula were removed. One day later, the patient’s chest X-rays showed partial resolution of lung edema. The patient was successfully extubated, and non-invasive ventilation with pulmonary rehabilitation was initiated to speed up her functional recovery. Full article
(This article belongs to the Special Issue Clinical Advances in Cardiac Anesthesia and Critical Care)
Show Figures

Figure 1

Figure 1
<p>(<b>A</b>) Chest X-rays showing persistent lung edema with bilateral infiltrates under mechanical ventilation and extracorporeal membrane oxygenation; (<b>B</b>) chest X-rays showing partial regression of lung edema and improved aeration on spontaneous ventilation after tracheal extubation.</p>
Full article ">Figure 2
<p>Timeline of key events (Cesarian section, respiratory failure and heart failure) and therapeutic interventions from hospital admission to weaning extracorporeal membrane oxygenation (ECMO) and mechanical ventilation followed by airflight transportation back to the referaal hospital.</p>
Full article ">
14 pages, 1317 KiB  
Review
Advances and Classification of Autonomous Systems in Biomedical Devices: Integration of Energy Harvesting and Ultra-Low Power Consumption
by José Alejandro Amezquita Garcia, Miguel E. Bravo Zanoguera and Fabian N. Murrieta-Rico
Electronics 2025, 14(1), 144; https://doi.org/10.3390/electronics14010144 - 1 Jan 2025
Viewed by 287
Abstract
Autonomous electronic systems are becoming increasingly important in people’s lives, as a result of advances in efficient energy storage systems, devices that can be permanently implanted in humans, and the trend towards compact devices that function as an extension of the human body. [...] Read more.
Autonomous electronic systems are becoming increasingly important in people’s lives, as a result of advances in efficient energy storage systems, devices that can be permanently implanted in humans, and the trend towards compact devices that function as an extension of the human body. In addition, strategies continue to be found for the integration of energy harvesting in a constant and efficient manner. Covering the numerous advances made in biomedical devices can be quite overwhelming. This work presents a review of the latest strategies developed to produce energy from human body activity, the energy collectors for devices, and the strategies to create ultra-low-power wearable devices. The review focuses on the potential energy sufficiency required to power devices that can be implanted or worn, while also providing information about the patient’s condition. A comparison between the energies produced by different instruments and the improvements in the development of low-consumption devices is presented, with a focus on the type of medical devices. A new approach is established to classify and locate the most recent advances in autonomous systems in biomedicine based on their complexity/function. Full article
Show Figures

Figure 1

Figure 1
<p>Different forms of extracting energy from the environment that surrounds the daily activities of a human being, either for storage or for use in a wearable device.</p>
Full article ">Figure 2
<p>General model of a biomedical acquisition system.</p>
Full article ">Figure 3
<p>Options for autonomous systems found in the research considered.</p>
Full article ">
15 pages, 5311 KiB  
Review
Local Anesthetic Infiltration, Awake Veno-Venous Extracorporeal Membrane Oxygenation, and Airway Management for Resection of a Giant Mediastinal Cyst: A Narrative Review and Case Report
by Felix Berger, Lennart Peters, Sebastian Reindl, Felix Girrbach, Philipp Simon and Christian Dumps
J. Clin. Med. 2025, 14(1), 165; https://doi.org/10.3390/jcm14010165 - 30 Dec 2024
Viewed by 216
Abstract
Background: Mediastinal mass syndrome represents a major threat to respiratory and cardiovascular integrity, with difficult evidence-based risk stratification for interdisciplinary management. Methods: We conducted a narrative review concerning risk stratification and difficult airway management of patients presenting with a large mediastinal mass. This [...] Read more.
Background: Mediastinal mass syndrome represents a major threat to respiratory and cardiovascular integrity, with difficult evidence-based risk stratification for interdisciplinary management. Methods: We conducted a narrative review concerning risk stratification and difficult airway management of patients presenting with a large mediastinal mass. This is supplemented by a case report illustrating our individual approach for a patient presenting with a subtotal tracheal stenosis due to a large cyst of the thyroid gland. Results: We identified numerous risk stratification grading systems and only a few case reports of regional anesthesia techniques for extracorporeal membrane oxygenation patients. Clinical Case: After consultation with his general physician because of exertional dyspnea and stridor, a 78-year-old patient with no history of heart failure was advised to present to a cardiology department under the suspicion of decompensated heart failure. Computed tomography imaging showed a large mediastinal mass that most likely originated from the left thyroid lobe, with subtotal obstruction of the trachea. Prior medical history included the implantation of a dual-chamber pacemaker because of a complete heart block in 2022, non-insulin-dependent diabetes mellitus type II, preterminal chronic renal failure with normal diuresis, arterial hypertension, and low-grade aortic insufficiency. After referral to our hospital, an interdisciplinary consultation including experienced cardiac anesthesiologists, thoracic surgeons, general surgeons, and cardiac surgeons decided on completing the resection via median sternotomy after awake cannulation for veno-venous extracorporeal membrane oxygenation via the right internal jugular and the femoral vein under regional anesthesia. An intermediate cervical plexus block and a suprainguinal fascia iliaca compartment block were performed, followed by anesthesia induction with bronchoscopy-guided placement of the endotracheal tube over the stenosed part of the trachea. The resection was performed with minimal blood loss. After the resection, an exit blockade of the dual chamber pacemaker prompted emergency surgical revision. The veno-venous extracorporeal membrane oxygenation was explanted after the operation in the operating room. The postoperative course was uneventful, and the patient was released home in stable condition. Conclusions: Awake veno-venous extracorporeal membrane oxygenation placed under local anesthetic infiltration with regional anesthesia techniques is a feasible individualized approach for patients with high risk of airway collapse, especially if the mediastinal mass critically alters tracheal anatomy. Compressible cysts may represent a subgroup with easy passage of an endotracheal tube. Interdisciplinary collaboration during the planning stage is essential for maximum patient safety. Prospective data regarding risk stratification for veno-venous extracorporeal membrane oxygenation cannulation and effectiveness of regional anesthesia is needed. Full article
(This article belongs to the Special Issue Clinical Advances in Cardiothoracic Anesthesia)
Show Figures

Figure 1

Figure 1
<p>Initial CT imaging of the (<b>a</b>) coronal plane and (<b>b</b>) axial plane: compression of the trachea (arrow: minimum diameter of 3 mm/subtotal collapse) due to the cyst (*), and a shift in anterior mediastinal structures to the right side of the patient.</p>
Full article ">Figure 2
<p>Preoperative chest X-ray with prominent tracheal deviation.</p>
Full article ">
12 pages, 12757 KiB  
Article
Multi-Scale Characterisation and Mechanical Adhesion in PVD-Deposited Ca-SZ Coating for Implantable Medical Devices
by Alex Tchinda, Richard Kouitat-Ndjiwa and Pierre Bravetti
Biomedicines 2025, 13(1), 37; https://doi.org/10.3390/biomedicines13010037 - 27 Dec 2024
Viewed by 258
Abstract
Oral implantology faces a multitude of technical challenges in light of current clinical experience, underlining the need for innovation in implantable medical devices in both mechanical and biological terms. Objectives: This study explores the influence of the thickness factor of calcium-doped zirconia (Ca-SZ) [...] Read more.
Oral implantology faces a multitude of technical challenges in light of current clinical experience, underlining the need for innovation in implantable medical devices in both mechanical and biological terms. Objectives: This study explores the influence of the thickness factor of calcium-doped zirconia (Ca-SZ) coatings deposited by PVD on their intrinsic mechanical properties and the determinism of the latter on adhesion to the TA6V alloy substrate after mechanical loading for applications in dental implantology. Methods: Three separate thicknesses of 250 nm, 450 nm and 850 nm were evaluated in terms of mechanical strength, modulus of elasticity and adhesion to the substrate, in accordance with ISO 20502:2005. Results: The results show an increase in apparent modulus of elasticity with thickness, reaching values of around 25.05 GPa and 36.3 GPa, close to the cortical bone for the 250 nm and 450 nm thick coatings, respectively. Adhesion tests show a progressive improvement up to 450 nm, followed by a similar observation at 850 nm, underlining the importance of optimal thickness to balance mechanical protection and biomechanical compatibility. Furthermore, the initial roughness and topography of the substrate were not influenced by the different thicknesses of the Ca-SZ coating. Conclusions: Together, these results reinforce the potential of Ca-SZ coatings to minimise stress shielding in dental implants. Full article
(This article belongs to the Section Biomedical Engineering and Materials)
Show Figures

Figure 1

Figure 1
<p>Three ×50 SEM micrographs of TA6V surfaces coated with 250 nm (<b>a</b>), 450 nm (<b>b</b>) and 850 nm (<b>c</b>) thick Ca-SZ (magnification ×50).</p>
Full article ">Figure 2
<p>Elemental EDS maps of Ca-SZ coatings of thicknesses 250 (<b>a</b>–<b>c</b>) 450 (<b>d</b>–<b>f</b>) and 850 nm (<b>g</b>–<b>i</b>).</p>
Full article ">Figure 3
<p>Three-dimensional surface profile of bare TA6V compared with TA6V surfaces coated with 250, 450 and 850 nm thick Ca-SZ.</p>
Full article ">Figure 4
<p>Evolution of topographic parameters Sa and Sq as a function of the thickness of the deposited Ca-SZ coating.</p>
Full article ">Figure 5
<p>SEM micrograph after scratch test of the Ca-SZ coatings at thicknesses of 250 (<b>A</b>), 450 (<b>B</b>) and 850 nm (<b>C</b>) associated with the critical loads measured (LC1, LC2 and LC3) for each thickness.</p>
Full article ">Figure 6
<p>SEM micrograph after scratch test of a bare TA6V surface (<b>A</b>) compared with 250nm thick Ca-SZ coatings (<b>C</b>). (<b>B</b>,<b>D</b>) are end-of-track images at ×500 magnification.</p>
Full article ">Figure 7
<p>EDS profiles of scratch tracks after scratch testing on a 250, 450 and 850 nm thick Ca-SZ coating. The spectra show the elemental distributions of zirconium (green), titanium (blue) and oxygen (red for 250 and 450 nm, pink for 850 nm) along the track, illustrating the evolution of the coating’s coverage and resistance as a function of its thickness. The tendency of the track is indicated by the yellow arrow at the bottom of the column for each coating thickness.</p>
Full article ">
10 pages, 1569 KiB  
Case Report
Cardiomyopathy in Non-Ambulatory Patients with Duchenne Muscular Dystrophy: Two Case Reports with Varying Outcomes, Considering Novel Treatments
by Marcello Marcì, Paola Vaccaro, Vincenzo Polizzi and Grazia Crescimanno
Reports 2025, 8(1), 2; https://doi.org/10.3390/reports8010002 (registering DOI) - 27 Dec 2024
Viewed by 290
Abstract
Background and Clinical Significance: Cardiomyopathy is a significant cause of mortality in patients with Duchenne muscular dystrophy (DMD). Key prognostic factors include the age of onset of cardiomyopathy, low body mass index (BMI), and poor respiratory function. Detection of cardiac abnormalities can be [...] Read more.
Background and Clinical Significance: Cardiomyopathy is a significant cause of mortality in patients with Duchenne muscular dystrophy (DMD). Key prognostic factors include the age of onset of cardiomyopathy, low body mass index (BMI), and poor respiratory function. Detection of cardiac abnormalities can be challenging, which complicates timely diagnosis and treatment. Common treatments for heart failure include ACE inhibitors, beta-blockers, and mineralocorticoids. However, their effectiveness can vary, and the progression of cardiomyopathy may differ from one patient to another. Ongoing research aims to identify better therapeutic strategies and biomarkers for early intervention, ultimately improving the quality of life for patients affected by cardiomyopathy. New medications for heart failure, such as sodium/glucose co-transporter 2 inhibitors (SGLT2i) and valsartan/sacubitril (V/S), have been proposed, but their safety and efficacy in DMD patients remain unknown. Case Presentation: We present two cases that illustrate the histories of two patients who experienced different outcomes. The management of the first patient was complicated by several factors, including an early onset of cardiomyopathy, intolerance to ACE inhibitors, and untreated scoliosis, which hindered the implantation of a cardioverter defibrillator (ICD). Unfortunately, he only benefited from dapagliflozin in the later stages of his cardiomyopathy. Neurological complications further exacerbated the advanced state of his disease. In contrast, the second patient adhered to all recommended therapies, including innovative medications, and he currently has compensated heart failure. Conclusions: We concluded that several factors, beyond genetic ones, may have influenced their prognosis, including updated guidelines for cardiomyopathy treatment and the utilization of innovative medications. Full article
(This article belongs to the Section Cardiology/Cardiovascular Medicine)
Show Figures

Figure 1

Figure 1
<p>Parasternal M-mode view shows internal dimensions of dilated left ventricle with reduced ejection fraction (EF about 35%). A: End Diastolic Diameter=60 mm; B: End Systolic Diameter=44 mm, Fractional Shortening = 26%).</p>
Full article ">Figure 2
<p>Cardiac magnetic resonance four-chamber view. Late gadolinium enhancement in the left ventricle wall (arrows) in a typical non-ischemic (mid-wall) distribution, due to extensive myocardial fibrosis.</p>
Full article ">Figure 3
<p>Percentage distribution of various treatments in our patients diagnosed with DMD and cardiomyopathy. ICD, implantable cardioverter defibrillator; MRA, mineralocorticoid receptor antagonists.</p>
Full article ">
11 pages, 502 KiB  
Article
The Severity of Prostaglandin-Associated Periorbitopathy Did Not Affect the Surgical Effectiveness of the Ahmed Glaucoma Valve
by Akiko Harano, Sho Ichioka, Kana Murakami, Mizuki Iida and Masaki Tanito
J. Clin. Med. 2025, 14(1), 42; https://doi.org/10.3390/jcm14010042 - 25 Dec 2024
Viewed by 230
Abstract
Introduction: To report the role of prostaglandin-associated periorbitopathy (PAP) severity on the surgical efficacy of Ahmed Glaucoma Valve (AGV) implantation. Subjects and Methods: Retrospective observational case series. Participants were the consecutive 102 eyes from 102 Japanese subjects (55 males, 47 females; [...] Read more.
Introduction: To report the role of prostaglandin-associated periorbitopathy (PAP) severity on the surgical efficacy of Ahmed Glaucoma Valve (AGV) implantation. Subjects and Methods: Retrospective observational case series. Participants were the consecutive 102 eyes from 102 Japanese subjects (55 males, 47 females; mean age ± standard deviation, 74.9 ± 7.8 years) who underwent AGV implantation for primary open-angle glaucoma (POAG), completed full postoperative visits for 12 months, and had information on PAP severity graded by the Shimane University PAP Grading System (SU-PAP). Data were collected via medical chart review. Comparison of surgical success rates among groups stratified by SU-PAP grades (grades 0–3) using survival curve analysis. Failure was defined based on additional glaucoma surgery, IOP reduction in less than 20%, postoperative IOP exceeding 18 mmHg (definition A) or 15 mmHg (definition B), or postoperative visual acuity reduced to no light perception. Results: At 12 months postoperatively, the success rates for grades 0, 1, 2, and 3 were 47%, 43%, 42%, and 73%, respectively, for definition A (p = 0.35) and 35%, 26%, 19%, and 27%, respectively, for definition B (p = 0.64, log-rank test). For definition A, younger age was associated with surgical failure (Hazard ratio = 0.97/year, p = 0.049, Wald test), while no other factors, including gender, preoperative IOP, medications, refractive error, history of conjunctival manipulation procedures, or SU-PAP grade, were associated with surgical failure. For definition B, no factors were found to influence surgical outcomes. Conclusions: The preoperative severity of PAP might not affect the postoperative outcomes of AGV. Given that the success rate of trabeculectomy is influenced by PAP severity, in cases with severe PAP, physicians are advised to consider long-tube shunt surgery as an initial filtration procedure or as a rescue procedure when filtration surgery is unsuccessful. Full article
(This article belongs to the Section Ophthalmology)
Show Figures

Figure 1

Figure 1
<p>The success rate of IOP control was evaluated for each SU-PAP grade group. In the survival curve analysis, the uncensored date was defined as the earliest occurrence of any of the following: IOP exceeding 18 mmHg (definition A) (<b>a</b>) or IOP exceeding 15 mmHg (definition B) (<b>b</b>); less than a 20% reduction in IOP; requirement for additional glaucoma surgery; and loss of light perception. Cases that did not meet these criteria by the final visit were treated as censored data.</p>
Full article ">
47 pages, 10687 KiB  
Review
A Review of Additive Manufacturing of Biodegradable Fe and Zn Alloys for Medical Implants Using Laser Powder Bed Fusion (LPBF)
by Irene Limón, Javier Bedmar, Juan Pablo Fernández-Hernán, Marta Multigner, Belén Torres, Joaquín Rams and Sandra C. Cifuentes
Materials 2024, 17(24), 6220; https://doi.org/10.3390/ma17246220 - 19 Dec 2024
Viewed by 583
Abstract
This review explores the advancements in additive manufacturing (AM) of biodegradable iron (Fe) and zinc (Zn) alloys, focusing on their potential for medical implants, particularly in vascular and bone applications. Fe alloys are noted for their superior mechanical properties and biocompatibility but exhibit [...] Read more.
This review explores the advancements in additive manufacturing (AM) of biodegradable iron (Fe) and zinc (Zn) alloys, focusing on their potential for medical implants, particularly in vascular and bone applications. Fe alloys are noted for their superior mechanical properties and biocompatibility but exhibit a slow corrosion rate, limiting their biodegradability. Strategies such as alloying with manganese (Mn) and optimizing microstructure via laser powder bed fusion (LPBF) have been employed to increase Fe’s corrosion rate and mechanical performance. Zn alloys, characterized by moderate biodegradation rates and biocompatible corrosion products, address the limitations of Fe, though their mechanical properties require improvement through alloying and microstructural refinement. LPBF has enabled the fabrication of dense and porous structures for both materials, with energy density optimization playing a critical role in achieving defect-free parts. Fe alloys exhibit higher strength and hardness, while Zn alloys offer better corrosion control and biocompatibility. In vitro and in vivo studies demonstrate promising outcomes for both materials, with Fe alloys excelling in load-bearing applications and Zn alloys in controlled degradation and vascular applications. Despite these advancements, challenges such as localized corrosion, cytotoxicity, and long-term performance require further investigation to fully harness the potential of AM-fabricated Fe and Zn biodegradable implants. Full article
Show Figures

Figure 1

Figure 1
<p>Applications of biodegradable metals in the medical devices industry. (<b>a</b>) Schematic diagram of cardiovascular diseases and stent [<a href="#B13-materials-17-06220" class="html-bibr">13</a>]. (<b>b</b>) Common medical devices used for fracture internal fixation Adapted with permission from [<a href="#B14-materials-17-06220" class="html-bibr">14</a>]. 2024 Elsevier. (<b>c</b>) Tissue engineering approach for reconstruction of large bone defects [<a href="#B15-materials-17-06220" class="html-bibr">15</a>].</p>
Full article ">Figure 2
<p>PRISMA flow diagram used for reporting systematic reviews [<a href="#B25-materials-17-06220" class="html-bibr">25</a>].</p>
Full article ">Figure 3
<p>Scheme from Li et al. showing the LPBF process at hatch distances of 120 μm (<b>a</b>) and 60 μm (<b>b</b>) Reprinted with permission from [<a href="#B35-materials-17-06220" class="html-bibr">35</a>]. 2024 Elsevier.</p>
Full article ">Figure 4
<p>Additive manufactured parts: (<b>a</b>) Adapted with permission from [<a href="#B51-materials-17-06220" class="html-bibr">51</a>], 2024, Elsevier (<b>b</b>) [<a href="#B56-materials-17-06220" class="html-bibr">56</a>], (<b>c</b>) Adapted with permission from [<a href="#B53-materials-17-06220" class="html-bibr">53</a>] 2024, Elsevier, (<b>d</b>) Adapted with permission from [<a href="#B54-materials-17-06220" class="html-bibr">54</a>] 2024, Elsevier and (<b>e</b>) [<a href="#B55-materials-17-06220" class="html-bibr">55</a>].</p>
Full article ">Figure 5
<p>Parts quality according to <span class="html-italic">E<sub>v</sub></span> and material. Green indicates optimum conditions, red excess of energy, and blue lack of energy [<a href="#B51-materials-17-06220" class="html-bibr">51</a>,<a href="#B52-materials-17-06220" class="html-bibr">52</a>,<a href="#B53-materials-17-06220" class="html-bibr">53</a>,<a href="#B54-materials-17-06220" class="html-bibr">54</a>,<a href="#B55-materials-17-06220" class="html-bibr">55</a>,<a href="#B56-materials-17-06220" class="html-bibr">56</a>].</p>
Full article ">Figure 6
<p>Preliminary study of processing parameters for hatch distance of 90 µm. The number at the top left is the relative density (%), the top right is the number of the sample and the number at the bottom left is the energy density (J/mm<sup>3</sup>) [<a href="#B56-materials-17-06220" class="html-bibr">56</a>].</p>
Full article ">Figure 7
<p>(<b>a</b>) Processing windows for pure iron (Zone I—Deformation zone, Zone II—Formation zone, Zone III—Zone of poor formation, and Zone IV—Zone of non-forming) versus laser power and scanning speed; Red square: parts manufactured with 100 W of laser power, green asterisks 80 W and blue triangles at 60 W. (<b>b</b>) Density curves of iron parts as a function of the laser power and scanning speed Adapted with permission from [<a href="#B51-materials-17-06220" class="html-bibr">51</a>]. 2024, Elsevier.</p>
Full article ">Figure 8
<p>Pure Fe cross-sectional optical micrographs (<b>a-1</b>,<b>b-1</b>) and Fe35Mn SEM images (<b>a-2</b>,<b>b-2</b>) showing the microstructure with BD out-of-plane and in-plane. Adapted with permission from [<a href="#B54-materials-17-06220" class="html-bibr">54</a>]. 2024, Elsevier.</p>
Full article ">Figure 9
<p>Top view and longitudinal cross-section of the CAD models of functionally graded Fe scaffold. Adapted with permission from [<a href="#B60-materials-17-06220" class="html-bibr">60</a>]. 2024, Elsevier.</p>
Full article ">Figure 10
<p>Corrosion rate of Fe and its alloys. In orange electrochemical tests and in blue immersion tests. Filled symbols correspond to dense parts and empty symbols correspond to scaffolds [<a href="#B52-materials-17-06220" class="html-bibr">52</a>,<a href="#B53-materials-17-06220" class="html-bibr">53</a>,<a href="#B55-materials-17-06220" class="html-bibr">55</a>,<a href="#B60-materials-17-06220" class="html-bibr">60</a>,<a href="#B63-materials-17-06220" class="html-bibr">63</a>,<a href="#B64-materials-17-06220" class="html-bibr">64</a>].</p>
Full article ">Figure 11
<p>Circuit for (<b>a</b>) pure iron. Adapted with permission from [<a href="#B52-materials-17-06220" class="html-bibr">52</a>] (2024, Elsevier) and (<b>b</b>) Fe35Mn scaffold. Adapted with permission from [<a href="#B53-materials-17-06220" class="html-bibr">53</a>] 2024, Elsevier.</p>
Full article ">Figure 12
<p>Volumetric energy densities (<span class="html-italic">E<sub>v</sub></span>) used for fabricating Zn and Zn alloys parts by LPBF. Green indicates optimum conditions, red excess of energy, and blue lack of energy [<a href="#B33-materials-17-06220" class="html-bibr">33</a>,<a href="#B77-materials-17-06220" class="html-bibr">77</a>,<a href="#B78-materials-17-06220" class="html-bibr">78</a>,<a href="#B79-materials-17-06220" class="html-bibr">79</a>,<a href="#B80-materials-17-06220" class="html-bibr">80</a>,<a href="#B81-materials-17-06220" class="html-bibr">81</a>,<a href="#B82-materials-17-06220" class="html-bibr">82</a>,<a href="#B83-materials-17-06220" class="html-bibr">83</a>,<a href="#B84-materials-17-06220" class="html-bibr">84</a>,<a href="#B85-materials-17-06220" class="html-bibr">85</a>].</p>
Full article ">Figure 13
<p>Appearance of LPBF-produced pure Zn parts showing the effect of fluence with (<b>a</b>) coarse particles and (<b>b</b>) fine particles Adapted with permission from [<a href="#B77-materials-17-06220" class="html-bibr">77</a>]. 2024, Elsevier.</p>
Full article ">Figure 14
<p>Picture of LPBF cross-sections of Zn-xWE43 bulk samples (<b>a</b>) Zn2WE43, (<b>b</b>) Zn5WE43 and (<b>c</b>) Zn8WE43 Adapted with permission from [<a href="#B80-materials-17-06220" class="html-bibr">80</a>]. 2024, Elsevier.</p>
Full article ">Figure 15
<p>Microhardness of high-density Zn and Zn alloy parts manufactured by LPBF [<a href="#B78-materials-17-06220" class="html-bibr">78</a>,<a href="#B80-materials-17-06220" class="html-bibr">80</a>,<a href="#B81-materials-17-06220" class="html-bibr">81</a>,<a href="#B84-materials-17-06220" class="html-bibr">84</a>,<a href="#B85-materials-17-06220" class="html-bibr">85</a>].</p>
Full article ">Figure 16
<p>Scanning electron microscopy top view for scaffolds with (<b>a</b>) diamond unit cell, (<b>b</b>) dodecahedron unit cell, (<b>c</b>) octet truss unit cell, (<b>d</b>) FCC unit cell, and (<b>e</b>) 3D Kagome unit cell Reprinted with permission from [<a href="#B86-materials-17-06220" class="html-bibr">86</a>]. 2024, Elsevier.</p>
Full article ">Figure 17
<p>Corrosion rate of Zn and its alloys. In orange electrochemical tests, in blue immersion tests. Filled symbols correspond to dense parts and empty symbols correspond to scaffolds [<a href="#B81-materials-17-06220" class="html-bibr">81</a>,<a href="#B82-materials-17-06220" class="html-bibr">82</a>,<a href="#B83-materials-17-06220" class="html-bibr">83</a>,<a href="#B84-materials-17-06220" class="html-bibr">84</a>,<a href="#B85-materials-17-06220" class="html-bibr">85</a>,<a href="#B88-materials-17-06220" class="html-bibr">88</a>,<a href="#B90-materials-17-06220" class="html-bibr">90</a>,<a href="#B91-materials-17-06220" class="html-bibr">91</a>].</p>
Full article ">Figure 18
<p>Equivalent electrical circuit for ZnxCe samples Reprinted with permission from [<a href="#B82-materials-17-06220" class="html-bibr">82</a>]. 2024, Elsevier.</p>
Full article ">Figure 19
<p>Quantitative viability results of MG-63 cells in extracts of LPBF processed ZnxMg. Data were normalized to the control group. Values were mean ±SD, n = 3, * <span class="html-italic">p</span> &lt; 0.05 between the test group and the pure Zn group Reprinted with permission from [<a href="#B83-materials-17-06220" class="html-bibr">83</a>]. 2024, Elsevier.</p>
Full article ">
13 pages, 1995 KiB  
Article
Accelerated Aging Effect on the Stability of the 3D-Printed Biodegradable Implant for Bone Defect Repairs
by Agnieszka Gutowska, Paweł Kubiak, Katarzyna Kośla, Bożena Wilbik-Hałgas, Edyta Chmal-Fudali, Agnieszka Kucharska-Jastrząbek and Marcin Henryk Struszczyk
Materials 2024, 17(24), 6218; https://doi.org/10.3390/ma17246218 - 19 Dec 2024
Viewed by 392
Abstract
This article presents an evaluation of the accelerated aging impact on the structural properties of biodegradable PLA/HAp implants produced using 3D printing technology for use in traumatic bone defect repairs in individual patients. The designed biodegradable implants were sterilized with a radiation dose [...] Read more.
This article presents an evaluation of the accelerated aging impact on the structural properties of biodegradable PLA/HAp implants produced using 3D printing technology for use in traumatic bone defect repairs in individual patients. The designed biodegradable implants were sterilized with a radiation dose of 25 ± 0.99% kGy, then exposed to an accelerated aging process. Selected physicomechanical and chemical properties of biodegradable implants were evaluated with FT-IR spectra analyses and DSC. The accelerated aging process, carried out according to the ASTM F 1980:2002 “Standard Guide for Accelerated Aging of Sterile Barrier Systems and Medical Devices”, simulates three years of implant usage. It confirmed the stability of structural, physical and mechanical properties and proved the effectiveness and safety of the implants’ application. The present study was conducted to determine the shelf-life of newly developed biodegradable implants proposed for the treatment of children and adolescents where bone growth still occurs by using accelerated aging methodologies, allowing the assessment of changes in performance that do not result in a negative impact on the safety of the medical device. Full article
(This article belongs to the Section Biomaterials)
Show Figures

Figure 1

Figure 1
<p>Implant model made by 3D printing from PLDLA filament: (<b>a</b>) sphere model (top and bottom view), (<b>b</b>) implant dimensions.</p>
Full article ">Figure 2
<p>Packaging system prototype for implant.</p>
Full article ">Figure 3
<p>FT-IR spectra of an implant after radiation sterilization with a dose of untreated 25 kGy and subjected to accelerated aging, simulating 3 years of storage in real conditions.</p>
Full article ">Figure 4
<p>DSC curve of the implant after radiation sterilization at a dose of 25 kGy, unaged and subjected to accelerated aging, simulating 3 years of storage in real conditions.</p>
Full article ">Figure 5
<p>Thickness of implant before and after accelerated aging.</p>
Full article ">Figure 6
<p>Areal density of implant samples before and after accelerated aging.</p>
Full article ">Figure 7
<p>Apparent density of implant before and after accelerated aging.</p>
Full article ">Figure 8
<p>Rounding height of implant before and after accelerated aging.</p>
Full article ">Figure 9
<p>Deflection for spherical surface implant before and after accelerated aging.</p>
Full article ">
16 pages, 5905 KiB  
Article
Corrosion Behavior of Ti and Ti6Al4V Alloy in Brackish Water, Seawater, and Seawater Bittern
by Ladislav Vrsalović, Senka Gudić, Antonia Talijančić, Jelena Jakić, Jure Krolo and Iman Danaee
Corros. Mater. Degrad. 2024, 5(4), 641-656; https://doi.org/10.3390/cmd5040031 - 19 Dec 2024
Viewed by 696
Abstract
Ti and Ti6Al4V alloy are extensively utilized in structural parts in engineering applications and the production of medical implants due to their excellent mechanical properties, lightweight, and high corrosion resistance. This study comprehensively evaluates their corrosion behavior in three challenging aquatic environments: brackish [...] Read more.
Ti and Ti6Al4V alloy are extensively utilized in structural parts in engineering applications and the production of medical implants due to their excellent mechanical properties, lightweight, and high corrosion resistance. This study comprehensively evaluates their corrosion behavior in three challenging aquatic environments: brackish water, seawater, and seawater bittern. Utilizing open circuit potential (EOC) measurements with polarization techniques (linear and potentiodynamic) and electrochemical impedance spectroscopy (EIS) measurements, the research highlights distinct environmental influences on corrosion performance. Notably, Ti and Ti6Al4V alloy demonstrated exceptional stability with the highest polarization resistance and lowest corrosion current in brackish water, while seawater bittern presented the most demanding condition for Ti6Al4V. Additionally, the analysis of the electrode surfaces after polarization measurements using optical microscopy, optical profilometry, and SEM/EDS tests revealed minor damage, indicating the high corrosion resistance of these materials. This study advances the understanding of Ti and Ti6Al4V alloy performance in diverse environments and offers valuable insights for optimizing their use in harsh aquatic conditions, particularly for applications requiring durability and longevity. Full article
Show Figures

Figure 1

Figure 1
<p>Open circuit potential measurements in brackish water, seawater, and seawater bittern for Ti (<b>a</b>) and Ti6Al4V alloy (<b>b</b>).</p>
Full article ">Figure 2
<p>Linear parts of <span class="html-italic">i</span>-<span class="html-italic">E</span> curves for Ti (<b>a</b>) and Ti6Al4V alloy (<b>b</b>) in brackish water, seawater, and seawater bittern.</p>
Full article ">Figure 3
<p>Potentiodynamic potential measurements in brackish water, seawater, and seawater bittern for Ti (<b>a</b>) and Ti6Al4V alloy (<b>b</b>).</p>
Full article ">Figure 4
<p>Nyquist (<b>a</b>,<b>b</b>) and Bode (<b>c</b>,<b>d</b>) plots recorded on cp-Ti and Ti-6Al-4V alloy in different solutions.</p>
Full article ">Figure 5
<p>The EC model used to fit the EIS data.</p>
Full article ">Figure 6
<p>Optical microscope images of surface of Ti after potentiodynamic polarization measurements in (<b>a</b>) brackish water, (<b>b</b>) seawater, and (<b>c</b>) seawater bittern; and surfaces of Ti6Al4V after measurements in (<b>d</b>) brackish water, (<b>e</b>) seawater, and (<b>f</b>) seawater bittern.</p>
Full article ">Figure 7
<p>SEM images of surface of Ti after potentiodynamic polarization measurements in (<b>a</b>) brackish water, (<b>b</b>) seawater, and (<b>c</b>) seawater bittern; and surfaces of Ti6Al4V after measurements in (<b>d</b>) brackish water, (<b>e</b>) seawater, and (<b>f</b>) seawater bittern.</p>
Full article ">Figure 7 Cont.
<p>SEM images of surface of Ti after potentiodynamic polarization measurements in (<b>a</b>) brackish water, (<b>b</b>) seawater, and (<b>c</b>) seawater bittern; and surfaces of Ti6Al4V after measurements in (<b>d</b>) brackish water, (<b>e</b>) seawater, and (<b>f</b>) seawater bittern.</p>
Full article ">Figure 8
<p>(<b>a</b>) SEM image of surface of Ti after potentiodynamic polarization measurements in seawater and (<b>b</b>) EDS point analysis in Spectrum 4.</p>
Full article ">Figure 9
<p>(<b>a</b>) SEM image of surface of Ti6Al4V after potentiodynamic polarization measurements in seawater bittern and (<b>b</b>) EDS point analysis in Spectrum 1.</p>
Full article ">Figure 10
<p>Three-dimensional optical profilometry images of surface of = Ti after potentiodynamic polarization measurements in (<b>a</b>) brackish water, (<b>b</b>) seawater, and (<b>c</b>) seawater bittern; and surfaces of Ti6Al4V after measurements in (<b>d</b>) brackish water, (<b>e</b>) seawater, and (<b>f</b>) seawater bittern.</p>
Full article ">Figure 11
<p>Three-dimensional appearance of corrosion pits and line profile measurement for Ti6Al4V electrode after potentiodynamic polarization measurements in seawater bittern.</p>
Full article ">
16 pages, 5649 KiB  
Article
Innovative Bioceramic Based on Hydroxyapatite with Titanium Nanoparticles as Reinforcement for Possible Medical Applications
by Dafne Rubi Porras-Herrera, Héctor Herrera-Hernández, José Guadalupe Miranda-Hernández, José Adalberto Castillo-Robles, Eddie Nahúm Armendariz-Mireles, Carlos Adrián Calles-Arriaga and Enrique Rocha-Rangel
J. Manuf. Mater. Process. 2024, 8(6), 296; https://doi.org/10.3390/jmmp8060296 - 19 Dec 2024
Viewed by 505
Abstract
Biomaterials have assumed a decisive role in modern medicine by enabling significant advancements in medical care practices. These materials are designed to interact with biological systems, offering substantial solutions for various medical needs. In this research, bioceramic materials consisting of a bioactive hydroxyapatite-based [...] Read more.
Biomaterials have assumed a decisive role in modern medicine by enabling significant advancements in medical care practices. These materials are designed to interact with biological systems, offering substantial solutions for various medical needs. In this research, bioceramic materials consisting of a bioactive hydroxyapatite-based matrix with Ti nanoparticles were processed as promising materials. These bioceramics were obtained using mechanical milling, uniaxial pressing, and sintering as powder processing techniques. This study evaluates the effect of Ti additions on the structural, electrochemical, and mechanical properties of the hydroxyapatite ceramic material. Titanium additions were about 1, 2 and 3 wt%. The experimental results demonstrate that the biocomposite’s structure has two hexagonal phases: one corresponding to the hydroxyapatite matrix and the other to the Ti as a reinforced phase. The biomaterials’ microstructure is completely fine and homogeneous. The biomaterial reinforced with 1 wt. % Ti exhibits the best mechanical behavior. In this context, electrochemical tests reveal that bioceramics can achieve stability through an ion adsorption mechanism when exposed to a physiological electrolyte. Bioceramics, particularly those containing 1%Ti, develop their bioactivity through the formation of a high-density hydroxide film during a porous sealing process at potentials around −782.71 mV, with an ionic charge transfer of 0.43 × 10−9 A/cm2. Finally, this biofilm behaves as a capacitor Cc = 0.18 nF/cm2, resulting in lower ionic charge transfer resistance (Rct = 1.526 × 106 Ω-cm2) at the interface. This mechanism promotes the material’s biocompatibility for bone integration as an implant material. Full article
(This article belongs to the Special Issue Industry 4.0: Manufacturing and Materials Processing)
Show Figures

Figure 1

Figure 1
<p>Design of the electrochemical cell of three-electrode configuration used for the corrosion testing of hydroxyapatite ceramic material.</p>
Full article ">Figure 2
<p>Experimental sequence of electrochemical test for corrosion evaluation of hydroxyapatite ceramic material in a 0.9% NaCl solution. The setup includes OCP monitoring, EIS, and anodic polarization test.</p>
Full article ">Figure 3
<p>Particle size distribution obtained in the different samples after the milling stage.</p>
Full article ">Figure 4
<p>X-ray diffraction pattern of the sample with 3% titanium.</p>
Full article ">Figure 5
<p>Microstructure of study samples taken under an optical microscope.</p>
Full article ">Figure 6
<p>Particle morphology of the fractured sample and after sintering.</p>
Full article ">Figure 7
<p>EDS analysis performed on 3% titanium sample.</p>
Full article ">Figure 8
<p>Porosity and microhardness of HPa as a function of titanium content.</p>
Full article ">Figure 9
<p>Elastic modulus and compressive strength of HPa as a function of titanium content.</p>
Full article ">Figure 10
<p>Fracture toughness of HPa as a function of titanium content.</p>
Full article ">Figure 11
<p>Open circuit potential transients of the bioceramic material HPa/Ti 1% sample after continuous exposure to a 0.9% NaCl solution for 504 h.</p>
Full article ">Figure 12
<p>Potentiodynamic polarization curves in the anodic branch.</p>
Full article ">Figure 13
<p>EIS response in Nyquist form of a bioceramic HPa/Ti1% sample during exposure in 0.9% NaCl solution at different periods of time, 5, 48, 168 and 504 h.</p>
Full article ">Figure 14
<p>EIS response in Bode form of a bioceramic HPa/Ti1% sample during exposure in 0.9% NaCl solution at different periods of time, 5, 48, 168 and 504 h.</p>
Full article ">Figure 15
<p>Equivalent electrical circuit (EEC) used to model the impedance behavior of bioceramic material exposed for 504 h in 0.9% NaCl. Rs: solution resistance; Cc: coating capacitance; Rct: charge transfer resistance; and Q: element phase constant.</p>
Full article ">
13 pages, 3921 KiB  
Article
Treatment of Periprosthetic Joint Infection with Intravenous Vancomycin: Do We Hit the Target?
by Rasmus Haglund, Ulrika Tornberg, Ann-Charlotte Claesson, Eva Freyhult and Nils P. Hailer
Antibiotics 2024, 13(12), 1226; https://doi.org/10.3390/antibiotics13121226 - 18 Dec 2024
Viewed by 710
Abstract
Background/objectives: Vancomycin is commonly used in the treatment of periprosthetic joint infection (PJI), and trough concentrations are measured to ascertain that they are within the therapeutic range. It has not been investigated what proportion of vancomycin concentrations during treatment of PJI patients [...] Read more.
Background/objectives: Vancomycin is commonly used in the treatment of periprosthetic joint infection (PJI), and trough concentrations are measured to ascertain that they are within the therapeutic range. It has not been investigated what proportion of vancomycin concentrations during treatment of PJI patients is accurately within this range, how many dose adjustments are commonly needed, and which patient factors predispose towards aberrations from the desired range. Method: In this single-center cohort study, we investigated vancomycin trough concentrations in 108 patients with surgically treated PJI who received IV administered vancomycin treatment post-operatively. Patients were identified in our local arthroplasty register, and data beyond what was available in the register were collected from electronic medical charts. Results: Of the final study cohort, 41% were women, and the median age was 71 (IQR 63–79) years. Most patients had PJI of the hip (73%), the majority (54%) underwent a debridement, antibiotics and implant retention (DAIR) procedure prior to vancomycin treatment, and 39% received vancomycin-loaded bone cement during the preceding revision procedure. Of 791 vancomycin trough measurements, only 58.2% were within the target range of 15–20 mg/L, 18.5% were below, and 23.4% were above. A total of 71% of all patients required at least one dose adjustment, and the median length of vancomycin treatment was 8 days. We observed positive correlations of vancomycin trough concentrations with both age (Spearman’s rho = 0.35, p < 0.001) and pre-treatment creatinine concentrations (Spearman’s rho = 0.34, p < 0.001), but no statistically significant difference between patients who had received vancomycin-loaded bone cement and those who had not. Conclusions: In our PJI patients, a high proportion of vancomycin trough concentrations were outside the therapeutic range, despite adherence to local and national guidelines. We can also confirm that caution needs to be exerted in patients of advanced age and those with compromised kidney function. Alternative broad-spectrum antibiotics that do not require as extensive therapeutic drug monitoring should be further explored. Full article
(This article belongs to the Section Pharmacokinetics and Pharmacodynamics of Drugs)
Show Figures

Figure 1

Figure 1
<p>Summary of all measured trough concentrations of vancomycin from all patients.</p>
Full article ">Figure 2
<p>All measured trough values of vancomycin (mg/L) per day after the index procedure. On some days (e.g., day 1), multiple measurements were obtained in some of the patients, indicated by numbers 1, 2 and 3 in the legend, and by different shades of gray in the graph. The red lines indicate the target range, points outside whiskers indicate outliers.</p>
Full article ">Figure 3
<p>Correlation between the ratio of the number of vancomycin trough measurements above the target range and age (Rho = 0.35, <span class="html-italic">p</span> &lt; 0.001). The blue line represents the linear fit.</p>
Full article ">Figure 4
<p>Correlation between the first measured vancomycin trough value (µmol/L) and the creatinine concentration (µmol/L) from the same day (Rho = 0.34, <span class="html-italic">p</span> &lt; 0.001). The blue line represents the linear fit.</p>
Full article ">Figure 5
<p>All measured creatinine concentrations (µmol/L) per day after the index procedure. On some days (e.g., day 1), multiple measurements were obtained in some of the patients, indicated by numbers 1, 2, 3, and 4 in the legend, and by shades of gray in the graph.</p>
Full article ">Figure 6
<p>Flowchart of the study population. Cosmic is the electronic medical record system used at our unit.</p>
Full article ">
14 pages, 9305 KiB  
Article
Nitrogen-Doped Diamond-like Coatings for Long-Term Enhanced Cell Adhesion on Electrospun Poly(ε-caprolactone) Scaffold Surfaces
by Semen Goreninskii, Yuri Yuriev, Artem Runts, Elisaveta Prosetskaya, Evgeniy Melnik, Tuan-Hoang Tran, Elizaveta Sviridova, Alexey Golovkin, Alexander Mishanin and Evgeny Bolbasov
Polymers 2024, 16(24), 3524; https://doi.org/10.3390/polym16243524 - 18 Dec 2024
Viewed by 357
Abstract
Electrospun poly(ε-caprolactone) (PCL)-based scaffolds are widely used in tissue engineering. However, low cell adhesion remains the key drawback of PCL scaffolds. It is well known that nitrogen-doped diamond-like carbon (N-DLC) coatings deposited on the surface of various implants are able to enhance their [...] Read more.
Electrospun poly(ε-caprolactone) (PCL)-based scaffolds are widely used in tissue engineering. However, low cell adhesion remains the key drawback of PCL scaffolds. It is well known that nitrogen-doped diamond-like carbon (N-DLC) coatings deposited on the surface of various implants are able to enhance their biocompatibility and functional properties. Herein, we report the utilization of the pulsed vacuum arc deposition (PVAD) technique for the fabrication of thin N-DLC coatings on the surface of electrospun PCL scaffolds. The effect of N-DLC coating deposition under various nitrogen pressures on the morphological, mechanical, physico-chemical, and biological properties of PCL scaffolds was investigated. It was established that an increase in nitrogen pressure in the range from 5 × 10−3 to 5 × 10−1 Pa results in up to a 10-fold increase in the nitrogen content and a 2-fold increase in the roughness of the PCL fiber surface. These factors provided the conditions for the enhanced adhesion and proliferation of human mesenchymal stem cells (MMSCs) on the surface of the modified PCL scaffolds. Importantly, the preservation of N-DLC coating properties determines the shelf life of a coated medical device. The elemental composition, tensile strength, and surface human MMSC adhesion were studied immediately after fabrication and after 6 months of storage under normal conditions. The enhanced MMSC adhesion was preserved after 6 months of storage of the modified PCL-based scaffolds under normal conditions. Full article
(This article belongs to the Special Issue Development and Application of Polymer Scaffolds, 2nd Volume)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>SEM images of the scaffolds and AFM images of the fiber surfaces.</p>
Full article ">Figure 2
<p>Average fiber diameter, root mean square roughness, coating thickness, tensile strength, and elongation of the scaffolds with N-DLC coatings deposited under various nitrogen pressures. *—<span class="html-italic">p</span> &lt; 0.05, statistically significant compared to the control (Kruskal–Wallis test); **—<span class="html-italic">p</span> &lt; 0.05, statistically significant compared to the group coated under nitrogen pressure of 5 × 10<sup>−3</sup> Pa (Kruskal–Wallis test).</p>
Full article ">Figure 3
<p>Elemental composition of the scaffold surfaces immediately after the deposition of N-DLC coatings (undashed bars) and after 6 months of storage (dashed bars). *—<span class="html-italic">p</span> &lt; 0.05, statistically significant compared to the control (Kruskal–Wallis test); **—<span class="html-italic">p</span> &lt; 0.05, statistically significant compared to the group coated under nitrogen pressure of 5 × 10<sup>−3</sup> Pa (Kruskal–Wallis test).</p>
Full article ">Figure 4
<p>MMSCs adhered to the surface of the fabricated scaffolds (×40 magnification). (<b>Left</b>) column—the cells cultured on the samples immediately after N-DLC coating deposition, (<b>right</b>) column—the cells cultured on the samples stored for 6 months. Cells cytoplasm stained in red, cells nuclei stained in purple blue.</p>
Full article ">Figure 5
<p>The density and morphology of MMSCs adhered to the surface of electrospun PCL scaffolds with N-DLC coatings deposited under various nitrogen pressures immediately after the deposition of N-DLC coatings (undashed bars) and after 6 months of storage (dashed bars). *—<span class="html-italic">p</span> &lt; 0.05, statistically significant compared to control (Mann–Whitney test).</p>
Full article ">Figure A1
<p>Typical stress–strain curves of the uncoated and coated scaffolds immediately after the coating deposition (<b>a</b>) and after 6 months of storage (<b>b</b>).</p>
Full article ">
15 pages, 1973 KiB  
Systematic Review
Meta-Analysis of MINIject vs. Two iStents as Standalone Treatment for Glaucoma with 24 Months of Follow-Up
by Jeremy C. K. Tan, Ashish Agar, Harsha L. Rao, Katherin Awad and Kaweh Mansouri
J. Clin. Med. 2024, 13(24), 7703; https://doi.org/10.3390/jcm13247703 - 17 Dec 2024
Viewed by 406
Abstract
Background: This study compares the long-term intraocular pressure (IOP)-lowering efficacy of standalone MINIject (iSTAR Medical, Belgium) suprachoroidal implantation and two iStent (Glaukos, CA, USA) trabecular bypass implantation using a systematic review and meta-analysis. Methods: Systematic review of standalone implantation of MINIject or iStent [...] Read more.
Background: This study compares the long-term intraocular pressure (IOP)-lowering efficacy of standalone MINIject (iSTAR Medical, Belgium) suprachoroidal implantation and two iStent (Glaukos, CA, USA) trabecular bypass implantation using a systematic review and meta-analysis. Methods: Systematic review of standalone implantation of MINIject or iStent inject with at least 24 months of follow up. The mean and standard deviation of IOP and the number of IOP-lowering medications at baseline and at 24 months were extracted. Weighted estimates of the outcome variables were calculated using random-effects meta-analysis models. Heterogeneity in the outcome measures among the studies was quantified using I². Results: Seven studies (three studies for MINIject and four for iStent) comprising 280 eyes were included. At 24 months, there was a greater reduction in IOP from baseline in the MINIject vs. two iStent cohorts (−9.57 vs. −4.92 mmHg, p = 0.03). The change from baseline in mean medication use was −1.00 with MINIject and −0.56 medications with iStent (p = 0.26). The mean percentage IOP reduction at 24 months ranged from 36.3−42.2% with MINIject compared to 5.2−40.7% with iStent, with greater variability in mean change from baseline in IOP observed in the iStent group (I2 = 96.5% vs. 0%). The most frequent adverse events for MINIject were anterior chamber inflammation, best-corrected visual acuity (BCVA) loss, hyphema, and conjunctival hemorrhage, and for iStent, these were device obstruction, BCVA loss, IOP spike, and cataract progression. Conclusions: While both MINIject and iStent inject devices resulted in significant reductions in IOP and IOP medication use, standalone MINIject may provide a greater and more consistent reduction in IOP. Full article
(This article belongs to the Section Ophthalmology)
Show Figures

Figure 1

Figure 1
<p>Preferred Reporting Items for Systematic Reviews and Meta-Analyses flow chart showing literature search.</p>
Full article ">Figure 2
<p>Forest plot evaluating mean baseline intraocular pressure in each study. IOP: intraocular pressure. The mean difference and 95% CI are calculated as a mean difference using <span class="html-italic">t</span>-test. “Test of group differences” provides the <span class="html-italic">p</span>-value for the indirect treatment comparison analysis [<a href="#B8-jcm-13-07703" class="html-bibr">8</a>,<a href="#B19-jcm-13-07703" class="html-bibr">19</a>,<a href="#B20-jcm-13-07703" class="html-bibr">20</a>,<a href="#B21-jcm-13-07703" class="html-bibr">21</a>].</p>
Full article ">Figure 3
<p>Forest plot evaluating mean baseline ocular glaucoma medications used in each study. IOP: intraocular pressure. The mean difference and 95% CI are calculated as a mean difference using <span class="html-italic">t</span>-test. “Test of group differences” provides the <span class="html-italic">p</span>-value for the indirect treatment comparison analysis [<a href="#B8-jcm-13-07703" class="html-bibr">8</a>,<a href="#B19-jcm-13-07703" class="html-bibr">19</a>,<a href="#B20-jcm-13-07703" class="html-bibr">20</a>,<a href="#B21-jcm-13-07703" class="html-bibr">21</a>].</p>
Full article ">Figure 4
<p>Mean change from baseline in IOP at 24 months (mmHg). IOP: intraocular pressure. The mean difference and 95% CI are calculated as a mean difference using <span class="html-italic">t</span>-test. “Test of group differences” provides the <span class="html-italic">p</span>-value for the indirect treatment comparison analysis [<a href="#B8-jcm-13-07703" class="html-bibr">8</a>,<a href="#B19-jcm-13-07703" class="html-bibr">19</a>,<a href="#B20-jcm-13-07703" class="html-bibr">20</a>,<a href="#B21-jcm-13-07703" class="html-bibr">21</a>].</p>
Full article ">Figure 5
<p>Mean change from baseline to month 24 in number of IOP-lowering medications. IOP: intraocular pressure. The mean difference and 95% CI are calculated as a mean difference using <span class="html-italic">t</span>-test. “Test of group differences” provides the <span class="html-italic">p</span>-value for the indirect treatment comparison analysis [<a href="#B8-jcm-13-07703" class="html-bibr">8</a>,<a href="#B20-jcm-13-07703" class="html-bibr">20</a>,<a href="#B21-jcm-13-07703" class="html-bibr">21</a>].</p>
Full article ">
Back to TopTop